BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
6/30/2024 7:39:33 AM | Browse: 230 | Download: 1356
Publication Name World Journal of Gastrointestinal Surgery
Manuscript ID 94482
Country China
ISSN 1948-9366 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright © The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology & Hepatology
Manuscript Type Clinical Trials Study
Article Title Clinical effect of spleen aminopeptide on improving liver function damage and immune function in children with infant hepatitis syndrome
Manuscript Source Unsolicited Manuscript
All Author List Xiao-Qing Fang, Tian Gan and Lie-Min Wang
ORCID
Author(s) ORCID Number
Lie-Min Wang http://orcid.org/0009-0004-4237-5131
Funding Agency and Grant Number
Corresponding Author Lie-Min Wang, BMed, Chief Nurse, Department of Neonatal, Central Hospital of Enshi, No. 88 Jinlong Avenue, Enshi 445000, Hubei Province, China. lieminwang@163.com
Key Words Infant hepatitis syndrome; Splenamin; Reduced glutathione; Liver function; Immune function; Complication
Core Tip In this study, infant hepatitis syndrome (IHS) is a clinical syndrome in infants less than one year of age with generalized skin jaundice, abnormal liver function, and hepatomegaly due to various etiologies such as infection. The comparative study of IHS was better treated with splenamine combined with reduced glutathione, which effectively improved patients' liver function and immune level, reduced adverse reactions, and provided some reference value for clinical treatment of IHS.
Publish Date 2024-06-30 07:39
Citation

Fang XQ, Gan T, Wang LM. Clinical effect of spleen aminopeptide on improving liver function damage and immune function in children with infant hepatitis syndrome. World J Gastrointest Surg 2024; 16(6): 1742-1748

URL https://www.wjgnet.com/1948-9366/full/v16/i6/1742.htm
DOI https://dx.doi.org/10.4240/wjgs.v16.i6.1742
Full Article (PDF) WJGS-16-1742-with-cover.pdf